| [1] |
Wong CX, Tse HF, Choi EK, et al. The burden of atrial fibrillation in the Asia-Pacific region[J]. Nat Rev Cardiol, 2024, 21(12):841-843.
|
| [2] |
Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study[J]. Circulation, 1998, 98(10):946-952.
|
| [3] |
Andrade J, Khairy P, Dobrev D, et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms[J]. Circ Res, 2014, 114(9):1453-1468.
|
| [4] |
Kim D, Yang PS, Yu HT, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort[J]. Eur Heart J, 2019, 40(28):2313-2323.
|
| [5] |
Tan S, Zhou J, Veang T, et al. Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046-a systematic analysis of the Global Burden of Disease Study 2021[J]. Europace, 2025, 27(2):euaf027.
|
| [6] |
Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2024, 149(1):e1-e156.
|
| [7] |
Brundel B, Ai X, Hills MT, et al. Atrial fibrillation[J]. Nat Rev Dis Primers, 2022, 8(1):21.
|
| [8] |
Hanna P, Buch E, Stavrakis S, et al. Neuroscientific therapies for atrial fibrillation[J]. Cardiovasc Res, 2021, 117(7):1732-1745.
|
| [9] |
Kirchhof P, Benussi S, Kotecha D, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) [J]. Eur Heart J, 2024, 45(36): 3314-414.
|
| [10] |
张友晶, 贾砚慧, 陈恕凤. 睡眠与心率变异性关系的研究进展[J/OL]. 中华心脏与心律电子杂志, 2023, 11(4): 242-246.
|
| [11] |
Goldberger JJ, Arora R, Buckley U, et al. Autonomic nervous system dysfunction: JACC focus seminar[J]. J Am Coll Cardiol, 2019, 73(10):1189-1206.
|
| [12] |
Armour JA, Murphy DA, Yuan BX, et al. Gross and microscopic anatomy of the human intrinsic cardiac nervous system[J]. Anat Rec, 1997, 247(2):289-298.
|
| [13] |
Pauza DH, Skripka V, Pauziene N, et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart[J]. Anat Rec, 2000, 259(4):353-382.
|
| [14] |
Scherschel K, Hedenus K, Jungen C, et al. Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation[J]. Sci Transl Med, 2019, 11(493): eaav7770.
|
| [15] |
Coumel P, Attuel P, Lavallée J, et al. [The atrial arrhythmia syndrome of vagal origin][J]. Arch Mal Coeur Vaiss, 1978, 71(6):645-656.
|
| [16] |
Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation[J]. Circulation, 2002, 105(23):2753-2759.
|
| [17] |
Sharifov OF, Fedorov VV, Beloshapko GG, et al. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs[J]. J Am Coll Cardiol, 2004, 43(3):483-490.
|
| [18] |
Ogawa M, Zhou S, Tan AY, et al. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure[J]. J Am Coll Cardiol, 2007, 50(4):335-343.
|
| [19] |
Tan AY, Zhou S, Ogawa M, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines[J]. Circulation, 2008, 118(9):916-925.
|
| [20] |
Qin M, Zeng C, Liu X. The cardiac autonomic nervous system: a target for modulation of atrial fibrillation[J]. Clin Cardiol, 2019, 42(6):644-652.
|
| [21] |
Lo LW, Scherlag BJ, Chang HY, et al. Paradoxical long-term proarrhythmic effects after ablating the "head station" ganglionated plexi of the vagal innervation to the heart[J]. Heart Rhythm, 2013, 10(5):751-757.
|
| [22] |
Choi EK, Shen MJ, Han S, et al. Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs[J]. Circulation, 2010, 121(24):2615-2623.
|
| [23] |
Chakraborty P, Farhat K, Po SS, et al. Autonomic nervous system and cardiac metabolism: links between autonomic and metabolic remodeling in atrial fibrillation[J]. JACC Clin Electrophysiol, 2023, 9(7 Pt 2):1196-1206.
|
| [24] |
Scherlag BJ. The ligament of Marshall: a historical perspective[J]. Heart Rhythm, 2021, 18(7):1088-1089.
|
| [25] |
Lin J, Scherlag BJ, Zhou J, et al. Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE)[J]. J Cardiovasc Electrophysiol, 2007, 18(11):1197-1205.
|
| [26] |
Nakagawa H, Scherlag BJ, Patterson E, et al. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation[J]. Heart Rhythm, 2009, 6(12 Suppl):S26-S34.
|
| [27] |
Lellouche N, Buch E, Celigoj A, et al. Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation[J]. J Am Coll Cardiol, 2007, 50(14):1324-1331.
|
| [28] |
Kim MY, Lim PB, Coyle C, et al. Single ectopy-triggering ganglionated plexus ablation without pulmonary vein isolation prevents atrial fibrillation[J]. JACC Case Rep, 2020, 2(12):2004-2009.
|
| [29] |
Scanavacca M, Pisani CF, Hachul D, et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation[J]. Circulation, 2006, 114(9):876-885.
|
| [30] |
Pokushalov E, Romanov A, Shugayev P, et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation[J]. Heart Rhythm, 2009, 6(9):1257-1264.
|
| [31] |
Katritsis D, Giazitzoglou E, Sougiannis D, et al. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation[J]. Am J Cardiol, 2008, 102(3):330-334.
|
| [32] |
Pokushalov E, Romanov A, Artyomenko S, et al. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation[J]. Pacing Clin Electrophysiol, 2010, 33(10):1231-1238.
|
| [33] |
Katritsis DG, Giazitzoglou E, Zografos T, et al. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study[J]. Heart Rhythm, 2011, 8(5):672-678.
|
| [34] |
Katritsis DG, Pokushalov E, Romanov A, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial[J]. J Am Coll Cardiol, 2013, 62(24):2318-2325.
|
| [35] |
Watanabe M, Kohno H, Kondo Y, et al. Is ganglionated plexus ablation effective for treating atrial fibrillation?[J]. Surg Today, 2018, 48(9):875-882.
|
| [36] |
Stirrup J, Gregg S, Baavour R, et al. Hybrid solid-state SPECT/CT left atrial innervation imaging for identification of left atrial ganglionated plexi: technique and validation in patients with atrial fibrillation[J]. J Nucl Cardiol, 2020, 27(6): 1939-1950.
|
| [37] |
Driessen AHG, Berger WR, Krul SPJ, et al. Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study [J]. J Am Coll Cardiol, 2016, 68(11): 1155-1165.
|
| [38] |
Romanov A, Pokushalov E, Ponomarev D, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: Three-year follow-up of a randomized study[J]. Heart Rhythm, 2019, 16(2):172-177.
|
| [39] |
Pokushalov E, Kozlov B, Romanov A, et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study[J]. Circ Arrhythm Electrophysiol, 2015, 8(6):1334-1341.
|
| [40] |
Waldron NH, Cooter M, Haney JC, et al. Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery[J]. Heart Rhythm, 2019, 16(2):178-184.
|
| [41] |
Wang H, Zhang Y, Xin F, et al. Calcium-induced autonomic denervation in patients with post-operative atrial fibrillation[J]. J Am Coll Cardiol, 2021, 77(1):57-67.
|
| [42] |
Yang Z, Tiemuerniyazi X, Xu F, et al. Partial Cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting: the pCAD-POAF randomized clinical trial[J]. JAMA Cardiol, 2025, 10(1):71-77.
|
| [43] |
Beaumont E, Southerland EM, Hardwick JC, et al. Vagus nerve stimulation mitigates intrinsic cardiac neuronal and adverse myocyte remodeling postmyocardial infarction[J]. Am J Physiol Heart Circ Physiol, 2015, 309(7):H1198-H1206.
|
| [44] |
Beaumont E, Wright GL, Southerland EM, et al. Vagus nerve stimulation mitigates intrinsic cardiac neuronal remodeling and cardiac hypertrophy induced by chronic pressure overload in guinea pig[J]. Am J Physiol Heart Circ Physiol, 2016, 310(10):H1349-1359.
|
| [45] |
Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway[J]. J Clin Invest, 2007, 117(2):289-296.
|
| [46] |
Ando M, Katare RG, Kakinuma Y, et al. Efferent vagal nerve stimulation protects heart againstischemia-induced arrhythmias by preserving connexin43 protein[J]. Circulation, 2005, 112(2):164-170.
|
| [47] |
Jiang Y, Su D, Xiao J, et al. Low-level auricular vagus nerve stimulation lowers blood pressure and heart rate in paroxysmal atrial fibrillation patients: a self-controlled study[J]. Front Neurosci, 2025, 19:1525027.
|
| [48] |
Stavrakis S, Humphrey MB, Scherlag B, et al. Low-level vagus nerve stimulation suppresses post-operative atrial fibrillation and inflammation: a randomized study[J]. JACC Clin Electrophysiol, 2017, 3(9):929-938.
|
| [49] |
Yu L, Scherlag BJ, Li S, et al. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation[J]. Heart Rhythm, 2013, 10(3):428-435.
|
| [50] |
Stavrakis S, Humphrey MB, Scherlag BJ, et al. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation[J]. J Am Coll Cardiol, 2015, 65(9):867-875.
|
| [51] |
Stavrakis S, Stoner JA, Humphrey MB, et al. TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): a randomized clinical trial[J]. JACC Clin Electrophysiol, 2020, 6(3):282-291.
|
| [52] |
Pokushalov E, Romanov A, Corbucci G, et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension[J]. J Am Coll Cardiol, 2012, 60(13):1163-1170.
|
| [53] |
Steinberg JS, Shabanov V, Ponomarev D, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial[J]. JAMA, 2020, 323(3):248-255.
|
| [54] |
Kiuchi MG, Chen S, Silva GR E, et al. The addition of renal sympathetic denervation to pulmonary vein isolation reduces recurrence of paroxysmal atrial fibrillation in chronic kidney disease patients[J]. J Interv Card Electrophysiol, 2017, 48(2):215-222.
|
| [55] |
Leftheriotis D, Flevari P, Kossyvakis C, et al. Acute effects of unilateral temporary stellate ganglion block on human atrial electrophysiological properties and atrial fibrillation inducibility[J]. Heart Rhythm, 2016, 13(11):2111-2117.
|
| [56] |
Connors CW, Craig WY, Buchanan SA, et al. Efficacy and efficiency of perioperative stellate ganglion blocks in cardiac surgery: a pilot study[J]. J Cardiothorac Vasc Anesth, 2018, 32(1):e28-e30.
|
| [57] |
Musikantow DR, Neuzil P, Petru J, et al. Pulsed field ablation to treat atrial fibrillation: autonomic nervous system effects[J]. JACC Clin Electrophysiol, 2023, 9(4):481-493.
|
| [58] |
Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation[J]. N Engl J Med, 2023, 389(18):1660-1671.
|
| [59] |
蒋子涵, 于丰源, 张宏达, 等. 2023年美国心律学年会心律失常领域最新临床研究进展[J/OL]. 中华心脏与心律电子杂志, 2023, 11(2):125-128.
|
| [60] |
中国医师协会心血管内科医师分会结构性心脏病学组, 苏州工业园区东方华夏心血管健康研究院. 中国经导管左心耳封堵术临床路径专家共识(2025版) [J/OL]. 中华心脏与心律电子杂志, 2025, 13(1): 1-28.
|
| [61] |
曹宾, 郭瑛, 夏盼盼, 等. 非阵发性心房颤动的治疗策略:来自心脏电生理一线医师的问卷调查[J/OL]. 中华心脏与心律电子杂志, 2023, 11(3):147-153.
|